Cargando…
Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer
Androgen deprivation therapy (ADT) is a systemic therapy for advanced prostate cancer (PCa). Although most patients initially respond to ADT, almost all cancers eventually develop castration resistance. Castration-resistant PCa (CRPC) is associated with a very poor prognosis, and the treatment of wh...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950316/ https://www.ncbi.nlm.nih.gov/pubmed/35335873 http://dx.doi.org/10.3390/pharmaceutics14030498 |